These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

4315 related items for PubMed ID: 4133186

  • 1. In vitro methods to complement in vivo approaches utilizing combinations of chemotherapy and immunotherapy.
    Sigel MM, Lichter W, Lopez DM.
    Cancer Chemother Rep 2; 1974 Mar; 4(1):109-14. PubMed ID: 4133186
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Rationale of combination chemotherapy based on preclinical experiments.
    Goldin A.
    Cancer Chemother Rep 3; 1973 Mar; 4(2):189-98. PubMed ID: 4580857
    [No Abstract] [Full Text] [Related]

  • 5. New agents and combinations in the treatment of bronchogenic carcinoma.
    Bodey GP, Gottlieb JA, Livingston R, Frei E.
    Cancer Chemother Rep 3; 1973 Mar; 4(2):227-9. PubMed ID: 4125740
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Potentially useful combinations of chemotherapy detected in mouse tumor systems.
    Kline I.
    Cancer Chemother Rep 2; 1974 Mar; 4(1):33-43. PubMed ID: 4133187
    [No Abstract] [Full Text] [Related]

  • 8. Cellular heterogeneity in malignant tumors. The importance of clonal interaction on tumor evolution, response to chemotherapy and metastatic ability evaluated in experimental systems.
    Aabo K.
    Dan Med Bull; 1996 Sep; 43(4):336-49. PubMed ID: 8884135
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Cancer and the lymphatic system].
    Grekh IF.
    Vopr Onkol; 1971 Sep; 17(10):101-10. PubMed ID: 4947716
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [A review of clinical tumor immunology. An approach to immunochemotherapy].
    Hattori T.
    Nihon Gan Chiryo Gakkai Shi; 1974 Nov 20; 9(4):381-90. PubMed ID: 4616062
    [No Abstract] [Full Text] [Related]

  • 15. Genes coding for tumor rejection antigens: perspectives for specific immunotherapy.
    Boon T, Coulie P, Marchand M, Weynants P, Wölfel T, Brichard V.
    Important Adv Oncol; 1994 Nov 20; ():53-69. PubMed ID: 8206495
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Combination chemotherapy for spontaneous AKR lymphoma.
    Schabel FM, Skipper HE, Trader MW, Laster WR, Cheeks JB.
    Cancer Chemother Rep 2; 1974 Mar 20; 4(1):53-72. PubMed ID: 4499910
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 216.